Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ADMA BIOLOGICS, INC.
| Metric | ADMA BIOLOGICS, INC. ADMAHealthcare |
|---|---|
| Quality Score | 63 / 100 |
| Revenue (latest) | $510M |
| Net income (latest) | $147M |
| Operating margin | 37.5% |
| Net margin | 28.8% |
| Return on equity | 30.8% |
| Return on assets | 23.5% |
| Return on capital (ROCE) | 34.5% |
| Debt / equity | 0.31× |
| Revenue growth (YoY) | 19.6% |
| Altman Z″ (distress) | 8.80 |
| Accruals / assets | 15.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.